TGIA, Inc.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
TGIA offers high-throughput next-generation and third-generation sequencing services in Taiwan, utilising industry-grade systems such as Illumina NovaSeq X Plus, NovaSeq 6000 and PacBio Sequel IIe.
Their service portfolio spans whole genome sequencing a
Their service portfolio spans whole genome sequencing a
The content above was translated by Ai
Founded Year
2017
Unified Business No.
52608581
Status
Active
Number of Employees
0
Total Paid-in
Capital
192,432,060 (NT$)
Location of Company
Taiwan
, Hsinchu County
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Taiwan Genomic Industry Alliance Inc. (TGIA) is a Taiwan-based company located in Nankang Software Park and, since 2022, headquartered in Hsinchu Biomedical Science Park as its operational and R&D center. Established under the guidance of the “Asia Pacific Biomedical Silicon Valley Precision Medicine Program” operated by the National Health Research Institutes (NHRI) in 2017, TGIA collaborates with NHRI through technology transfer to become a leading player in disease, genetics and cancer-genetics sequencing, serving as an important medical hub in the Asia-Pacific region
The content above was translated by Ai
